Effect of opioid receptor ligands injected into the rostral lateral hypothalamus on c-fos and feeding behavior
Keywords: DREAM; Naltrexone; DAMGO; Dynorphin; Morphine; U-50488H
مقالات ISI DREAM (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Blocking polysynaptic inhibition via opioid receptor activation isolates excitatory synaptic currents without triggering epileptiform activity in organotypic hippocampal slices
Keywords: DREAM; Hippocampus; Synaptic transmission; Synaptic inhibition; CA3; Opioid; DAMGO; Epilepsy
Pharmacological characterization of high-fat feeding induced by opioid stimulation of the ventral striatum
Keywords: DREAM; Nucleus accumbens; Palatability; Food reward; Dopamine; Glutamite; Cholinergic; Naltrexone; Scopolamine; Feeding; DAMGO
Nucleus accumbens opioids regulate flavor-based preferences in food consumption
Keywords: DREAM; opioids; nucleus accumbens; feeding; palatability; choice; ANOVA; analysis of variance; DAMGO; d-Ala2,N,Me-Phe4,Gly-ol5-enkephalin; MOP; μ opioid; NAcc; nucleus accumbens;
Modulation of Na, K-ATPase activity by prostaglandin E1 and [d-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin
Keywords: DREAM; Calcium; DAMGO; PGE1; Protein kinase A; Protein kinase C; Sodium pump; SH-SY5Y
Contribution of the kinetics of G protein dissociation to the characteristic modifications of N-type calcium channel activity
Keywords: DREAM; GPCR; G protein coupled receptors; DAMGO; d-Ala2,Me-Phe4,glycinol5)-enkephalin; Calcium channel; N-type channel; G protein regulation; μ-Opioid receptor; β-Subunit; Prepulse facilitation; Channel reluctance;
δ-opioid receptor-mediated actions on rostral ventromedial medulla neurons
Keywords: DREAM; ACSF; artificial cerebrospinal fluid; BSA; bovine serum albumin; DAMGO; [d-Ala2, NMe-Phe4, Gly-ol5]-enkephalin; deltorphin-II; [d-Ala2]-deltorphin II; DPDPE; [d-Pen2; d-Pen5]-enkephalin; RVM; rostral ventromedial medulla; TPH; tryptophan hydroxylase; TPH-
μ opioid receptor agonist DAMGO-induced suppression of saccharin intake in Lewis and Fischer rats
Keywords: DREAM; Neural basis of behavior; Drugs of abuse: opioids and others; DAMGO; Opioid; Saccharin; Conditioned taste aversion; Reward comparison; Rat; Anticipatory contrast;
μ-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons
Keywords: DREAM; phospholipase A2; 4AP-sensitive potassium channel; reward; analgesia; AP5; 2-amino-5-phosphonovaleric acid; BLA; basolateral nucleus of the amygdala; CeA; central nucleus of the amygdala; CNQX; 6-cyano-7-nitroquinoxaline-2,3-dione; DAMGO; [d-Ala2,N-MePhe4
Reduced suppression of CO2-induced ventilatory stimulation by endomorphins relative to morphine
Keywords: DREAM; Neurotransmitters, modulators, transporters, and receptors; Opioids: anatomy, physiology, and behavior; EM1; endomorphin-1; EM2; endomorphin-2; DAMGO; Tyr-d-Ala-Gly-MePhe-Gly-ol; MS; morphine sulfate; HCVR; hypercapnic ventilatory response; MOR; mu-opioid
Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in μ-opioid receptor knockout mice
Keywords: DREAM; opioids; addiction; ventral tegmental area; GABA; dopamine; cocaine; aCSF; artificial cerebrospinal fluid; CPP; conditioned place preference; DAMGO; [d-Ala, Nme-Phe, Gly-ol]-enkephalin; mIPSC; miniature inhibitory post-synaptic current; MOR; μ-opioid rec
Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: Comparison with the distribution of mu, delta and kappa binding sites
Keywords: DREAM; AcbC; nucleus accumbens,core; BLA; basolateral nucleus of the amygdala; CA3; CA3 region of the hippocampus; cl; claustrum; CG; central gray; CI, 977; (â)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4,5]dec-8-yl]-4-benzofuranacetamide; CPu; caudate; CTR; c
Opioids: cellular mechanisms of tolerance and physical dependence
Keywords: DREAM; AC; adenylyl cyclase; CREB; cAMP response element binding protein; DAMGO; [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin; DOR; δ-opioid receptor; GABA; γ-aminobutyric acid; GAT-1; GABA transporter; GRK; G-protein-coupled receptor kinase; LC; locus coeruleus; M
Antinociception following application of DAMGO to the basolateral amygdala results from a direct interaction of DAMGO with Mu opioid receptors in the amygdala
Keywords: DREAM; Sensory systems; Pain modulation: pharmacology; Mu receptor; DAMGO; Analgesia; Amygdala; Tail flick; G protein;
μ-Opioids disinhibit and κ-opioids inhibit serotonin efflux in the dorsal raphe nucleus
Keywords: DREAM; Neurotransmitters, modulators, transporters and receptors; Serotonin; 5-HT; 5-hydroxytryptamine, serotonin; DRN; dorsal raphe nucleus; PAG; periaqueductal gray; NAcc; nucleus accumbens; GABA; γ-aminobutyric acid; AP-5; (±)-2-amino-5-phosphonopentanoic a
Neuronal nitric oxide modulates morphine antinociceptive tolerance by enhancing constitutive activity of the μ-opioid receptor
Keywords: DREAM; DAMGO; [D-Ala2, N-MePhe4, Gly-ol5]enkephalin; GDP; guanosine diphosphate; GPCR; G-protein-coupled receptor; GppNHp; 5â²guanylylimidodiphosphate; GTPγS; guanosine5â²-G-(3-thio)triphosphate; NaCl; sodium chloride; NO; nitric oxide; Constitutive activity;
Purification and mass spectrometric analysis of the δ opioid receptor
Keywords: DREAM; Neurotransmitters, modulators, transporters, and receptors; Opioid receptors; DADL; [d-Ala2, d-Leu5]enkephalin; DAMGO; [d-Ala2, N-Me-Phe4,Gly5-ol]enkephalin; HEK; human embryonic kidney; MALDI; matrix-assisted laser desorption ionization; ms/ms; tandem ma
Effect of a selective GABAB receptor agonist baclofen on the μ-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects
Keywords: DREAM; Emesis; Antinociception; Rewarding effect; Baclofen; Ferret; DMN; dorsal motor nucleus; GABA; γ-aminobutyric acid; CGP 35348; (3-Aminopropyl)(diethoxymetyl)phosphinic acid; CNS; central nervous system; DAMGO; [d-Ala2,N-Me-Phe4,Gly5-ol]enkephalin; DVC; do
Enhanced striatal opioid receptor-mediated G-protein activation in l-dopa-treated dyskinetic monkeys
Keywords: DREAM; Parkinson's disease; motor complication; primate model; opioid receptor G-protein coupling; autoradiograph; ANOVA; analysis of variance; DAMGO; [d-Ala, N-Me-Phe, Gly-ol]-enkephalin; GPe; external globus pallidus; GPi; internal globus pallidus; l-dopa; l
Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens
Keywords: DREAM; opioid receptors; receptor interaction; nucleus accumbens; dopamine release; rats; ANOVA; analysis of variance; BNTX; (E)-7-benzylidenenaltrexone; CTOP; d-Phe-Cys-Tyr-d-Trp-Orn-Thr-Phe-Thr-NH2; DAMGO; [d-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin; DPDPE; [d-Pen2,
N-methyl-d-aspartate receptors and large conductance calcium-sensitive potassium channels inhibit the release of opioid peptides that induce μ-opioid receptor internalization in the rat spinal cord
Keywords: DREAM; dorsal horn; dynorphin; enkephalin; internalization; mu-opioid receptor; opioid; aCSF; artificial cerebrospinal fluid; ANOVA; analysis of variance; AP-5; dl-2-amino-5-phosphonopentanoic acid; BK(Ca2+); large conductance Ca2+-sensitive K+ channels; CCK; ch